Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    10403727 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
Condition: Non-erosive Reflux Disease
Interventions: Drug: Esomeprazole;   Drug: Placebo
2 Completed Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
Conditions: Esophagitis;   Gastroesophageal Reflux;   Stomach Ulcer;   Duodenal Ulcer
Intervention: Drug: S-Tenatoprazole-Na (STU-Na)
3 Completed Lidocaine Spray on an Endoscope to Improve Tolerance to Endoscopy
Conditions: C.Medical Procedure; Digestive System;   Disorder of Upper Gastrointestinal Tract;   Tolerance
Intervention: Drug: Case Group
4 Withdrawn Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplication (TIF) Using EsophyX for the Treatment of GERD
Condition: Gastroesophageal Reflux Disease (GERD)
Intervention: Device: EsophyX™ system with SerosaFuse fasteners
5 Suspended Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis
Condition: Esophagitis, Reflux
Intervention: Drug: S-Tenatoprazole-Na (STU-Na)

Indicates status has not been verified in more than two years